Globus Medical Inc
GMED· NYSE
GMEDGlobus Medical Inc
Released Aug 6, 2026, after the close
10-Q filed Aug 6, 2026, 37 days after period end · 0001628280-26-054450
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $789.61M | $745.34M | $629.69M | $291.62M |
| Net Income | $151.57M | $202.85M | $31.76M | $57.71M |
| EPS Diluted |
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR
| $1.10 |
| $1.49 |
| $0.23 |
| $0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
